Clinical aspects of coenzyme Q10: an update

@article{Littarru2005ClinicalAO,
  title={Clinical aspects of coenzyme Q10: an update},
  author={Gian Paolo Littarru and Luca Tiano},
  journal={Current Opinion in Clinical Nutrition and Metabolic Care},
  year={2005},
  volume={8},
  pages={641–646}
}
  • G. Littarru, Luca Tiano
  • Published 1 November 2005
  • Biology, Medicine
  • Current Opinion in Clinical Nutrition and Metabolic Care
Purpose of reviewCoenzyme Q10 is administered for an ever-widening range of disorders, therefore it is timely to illustrate the latest findings with special emphasis on areas in which this therapeutic approach is completely new. These findings also give further insight into the biochemical mechanisms underlying clinical involvement of coenzyme Q10. Recent findingsCardiovascular properties of coenzyme Q10 have been further addressed, namely regarding myocardial protection during cardiac surgery… Expand
Clinical aspects of coenzyme Q10: an update.
The fundamental role of coenzyme Q(10) (CoQ(10)) in mitochondrial bioenergetics and its well-acknowledged antioxidant properties constitute the basis for its clinical applications, although some ofExpand
Clinical applications of coenzyme Q10.
TLDR
Recent data indicate that CoQ10 affects expression of genes involved in human cell signalling, metabolism and transport and some of the effects of CoQ20 supplementation may be due to this property, which may provide a significant symptomatic benefit. Expand
Coenzyme Q10 and statins: biochemical and clinical implications.
TLDR
Physicians should be aware of this drug-nutrient interaction and be vigilant to the possibility that statin drugs may, in some cases, impair skeletal muscle and myocardial bioenergetics. Expand
An update of Coenzyme Q10 implications in male infertility: Biochemical and therapeutic aspects
TLDR
The relative distribution of the quinone between these two compartments was studied in infertile men, and the reduction state of CoQ10 in seminal fluid was also investigated. Expand
Coenzyme Q10 in Equine Serum: Response to Supplementation
TLDR
The data show that horse serum contains CoQ as CoQ10, at a much lower concentration as compared with that of humans and several other species, and there is no evidence for the presence of coenzyme Q9 or other homologs of CoQ. Expand
Effect of coenzyme Q 10 supplementation on heart failure : a meta-analysis 1 – 3 A
Background: Coenzyme Q10 (CoQ10; also called ubiquinone) is an antioxidant that has been postulated to improve functional status in congestive heart failure (CHF). Several randomized controlledExpand
Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial
TLDR
The results highlight the potential of Qred to modulate the overexpression of inflammatory and thrombotic risk markers in APS and suggest it might act as safe adjunct to standard therapies in APs. Expand
Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis.
TLDR
Pooled analyses of available randomized controlled trials suggest that CoQ₁₀ may improve the EF in patients with CHF. Expand
Coenzyme Q10 in Male Infertility
This chapter deals with the role of coenzyme Q10 in male infertility in the light of the increasing evidence of oxidative damage and antioxidant defence in sperm cells and seminal plasma. ReactiveExpand
Prolonged coenzyme Q10 treatment in Down syndrome patients, effect on DNA oxidation
TLDR
An age-specific reduction in the percentage of cells showing the highest amount of oxidized bases is highlighted, indicating a potential role of CoQ(10) in modulating DNA repair mechanisms. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.
TLDR
Preoperative oral coenzyme Q(10) therapy in patients undergoing cardiac surgery increases myocardial and cardiac mitochondrial coen enzymes levels, improves mitochondrial efficiency, and increases myCardial tolerance to in vitro hypoxia-reoxygenation stress. Expand
Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes)
TLDR
Efficacy of this therapy in this patient is correlated to control of lactic acidosis and serum creatine kinase levels, and the unpredictable a priori efficacy of therapy suggests that a long-term trial of oral coenzyme Q may be warranted. Expand
Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
TLDR
This therapy resulted in sustained improvement in mitochondrial energy synthesis that was associated with a slowing of the progression of certain clinical features and a significant improvement in cardiac function. Expand
Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
TLDR
The complete recovery of myopathy with exogenous CoQ(10) supplementation observed in this patient highlights the importance of early identification and treatment of this genetic disorder. Expand
Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients
TLDR
The data support the presence of a generalised mitochondrial defect in at least a subgroup of patients with PD that can be partially ameliorated in vitro by coenzyme Q(10) treatment. Expand
Long‐term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency
TLDR
The results indicate that CoQ has clinical value in the long-term management of patients with mitochondrial encephalomyopathies, even though there are clinical limitations to the effects of this therapy. Expand
Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.
TLDR
It is demonstrated for the first time that there is a significant increase in ATP synthetic capacity in lymphocytes from patients undergoing cofactor treatment, which supports the proposal that CoQ(10) may have a beneficial effect in the treatment of oxidative phosphorylation (OXPHOS) disorders. Expand
Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end‐points of “Q‐symbio” ‐ A multinational trial
TLDR
A reduced myocardial tissue content of the essential redox‐component and natural antioxidant Coenzyme Q10 (CoQ10) has been detected in patients with heart failure and the observed level of CoQ10 deficiency was correlated to the severity of heart failure. Expand
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
TLDR
The data suggest that in future studies of coenzyme Q10 in PD, a dosage of 2400 mg/day (with vitamin E/alpha-tocopherol 1200 IU/day) is an appropriate highest dosage to be studied. Expand
Coenzyme Q10 Combined With Mild Hypothermia After Cardiac Arrest: A Preliminary Study
TLDR
Combining CoQ10 with mild hypothermia immediately after CPR appears to improve survival and may improve neurological outcome in survivors, and coenzyme Q10 has shown a protective effect in neurodegenerative disorders. Expand
...
1
2
3
...